Mortality of children and adolescents co-infected with tuberculosis and HIV: a systematic review and meta-analysis
Fei‐Hong Hu, Xiaolei Tang, Meng‐Wei Ge, Yi‐Jie Jia, Wanqing Zhang, Wen Tang, Lu-Ting Shen, Wei Du, et al. (10 authors)
AIDS · 2024-03
Abstract
OBJECTIVE: Children and adolescents with HIV infection are well known to face a heightened risk of tuberculosis. However, the exact mortality rates and temporal trends of those with HIV-tuberculosis (TB) co-infection remain unclear. We aimed to identify the overall mortality and temporal trends within this population. METHODS: PubMed, Web of Science, and Embase were employed to search for publications reporting on the mortality rates of children and adolescents with HIV-TB co-infection from inception to March 2, 2024. The outcome is the mortality rate for children and adolescents with HIV-TB co-infection during the follow-up period. In addition, we evaluate the temporal trends of mortality. RESULTS: During the follow-up period, the pooled mortality was 16% [95% confidence interval (CI) 13-20]. Single infection of either HIV or TB exhibit lower mortality rates (6% and 4%, respectively). We observed elevated mortality risks among individuals aged less than 12 months, those with extrapulmonary TB, poor adherence to ART, and severe immunosuppression. In addition, we observed a decreasing trend in mortality before 2008 and an increasing trend after 2008, although the trends were not statistically significant ( P = 0.08 and 0.2 respectively). CONCLUSIONS: Children and adolescents with HIV-TB co-infection bear a significant burden of mortality. Timely screening, effective treatment, and a comprehensive follow-up system contribute to reducing the mortality burden in this population.
MeSH terms
- Medicine
- Tuberculosis
- Mortality rate
- Population
- Human immunodeficiency virus (HIV)
- Immunosuppression
- Meta-analysis
- Pediatrics
- Demography
- Immunology